Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Great news this just after CEO (Cathal Friel) bought again recently of course...
22 February 2024 - Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it has received notification that on 21 February 2024, Jeremy Skillington, Chief Executive Officer of the Company, purchased 154,764 ordinary shares at a price of 10.8 pence per share (the "Purchase").
Following the Purchase, Jeremy holds 873,497 ordinary shares representing approximately 0.17 per cent of the Company's issued share capital.
“…Anything that we own is for sale at the right price, in the right circumstances of course. We’re seeing a huge amount of deal flow and we’ve come very, very close to making some investments…”
INTERVIEW LINK ONLY :
https://youtu.be/A_WH5IBt7Ko
FULL ARTICLE PLUS INTERVIEW LINK :
https://total-market-solutions.com/2024/02/seed-innovations-ltd-feb-2024/
“…We’re in production. We’re making profit. We pay dividends and share buybacks. Everything is absolutely good. All I’m interested in is profit…”
https://total-market-solutions.com/2024/02/union-jack-oil-plc-feb-2024/
Cathal Friel, Executive Chairman of the Company, purchased 830,000 ordinary shares at a price of 11.68 pence per share
Following the Purchase, Cathal holds 37,219,757 ordinary shares representing approximately 7.4 per cent of the Company's issued share capital.
https://www.londonstockexchange.com/news-article/POLB/director-share-purchase/16339234
They have highlighted this on their social media:
https://twitter.com/PoolbegPharma/status/1758446020168491467
"As part of my ongoing commitment to the Company, I also intend to start increasing my shareholding in Poolbeg as and when I am able to do so."
https://www.londonstockexchange.com/news-article/POLB/board-role-change-and-launch-of-eip/16333439
Https://www.investorschronicle.co.uk/ideas/2024/02/12/business-is-booming-at-hvivo/
Research conducted on behalf of Poolbeg confirms a > US$10 billion market opportunity for POLB 001 in Cancer Immunotherapy-Induced CRS as an orally delivered preventative therapy.
Cancer immunotherapies have been approved in rare and orphan blood cancers and so the Company can see potential for POLB 001 in one or more of these cancer types.
https://www.londonstockexchange.com/news-article/POLB/market-opportunity-for-polb-001-for-crs/16327313
POLB 001 in cancer immunotherapy-induced CRS will be developed alongside Poolbeg’s existing portfolio of assets including their influenza programme, AI drug discovery programmes and oral delivery of GLP-1 for obesity and other metabolic diseases.
After these significant results, what does the next exciting chapter for ECR Minerals start to feel like ask @TMSreach
“…we’ve got some tax losses that could be quite valuable in the right hands and to others in our space…”
Full article with Video : https://total-market-solutions.com/2024/02/ecr-minerals-plc-feb-2024/
Video Interview only : https://youtu.be/G4sJEHN8Nxo
“…Since making its potentially transformative acquisition URAH has made solid progress towards bringing the mine back into production on a modest budget…”
https://total-market-solutions.com/2024/02/ura-holdings-plc-2/
“…Amryt was a fantastic journey and story. We helped numerous patients worldwide, and the value creation followed and that’s what we’re going to do with Poolbeg…”
Full Article plus interview :
https://total-market-solutions.com/2024/02/poolbeg-pharma-plc-copy/
Interview only :
https://youtu.be/ZF-1MoycuXc
This morning’s interview introducing Laura Maher, the #POLB VP of Clinical Operations:
https://twitter.com/PoolbegPharma/status/1755133379857567838
“…The share price has, however, begun to recover over the past few days, momentum that might be sustained by this week’s confirmation of the Record Date for eligibility for potential proceeds from the claim against the Republic…”
https://total-market-solutions.com/2024/02/ascent-resources-plc-2/
“…With a headline figure of 37 million ounces of gold the acquisition certainly has transformative potential…”
https://total-market-solutions.com/2024/02/lexington-gold-ltd-7/
JP Morgan announcing their significant holding in hVIVO plc:
https://polaris.brighterir.com/public/hvivo/news/rns/story/rn4g70x
Read the RNS...
...or listen to the CEO
this facility is more for headroom. An ICON facility. Saves OCTP issuing an expensive prospectus (Maybe £200-300k)
https://total-market-solutions.com/2024/01/oxford-cannabinoid-technologies-holdings-plc-jan-2024/